Findings

What do systematic reviews say?

4,410 questions · 8,901 findings · 1,091 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,687 · 19%GRADE not reported 1,469 · 16.5%Very low 1,969 · 22.1%Low 2,060 · 23.1%Moderate 1,302 · 14.6%High 414 · 4.7%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Iridotomy vs no iridotomy

Mean number of antiglaucoma medications at 1‐year · people with primary angle‐closure suspect

The review found no eligible studies for this question.

1 finding from 1 review

Iridotomy to slow progression of visual field loss in angle‐closure glaucoma 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Iridotomy vs no iridotomy

Quality of life measures · people with primary angle‐closure suspect

The review found no eligible studies for this question.

1 finding from 1 review

Iridotomy to slow progression of visual field loss in angle‐closure glaucoma 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Iridotomy vs no iridotomy

Adverse events · people with primary angle‐closure suspect

Iridotomy showed no clear difference in adverse events compared with no iridotomy (low certainty).

1 finding from 1 review

Iridotomy to slow progression of visual field loss in angle‐closure glaucoma 2023 · Cochrane Headline outcomes only
RR 13.7 [0.73, 230.42]
Studies not reported
Low

Intervention not reported

Breast cancer stage at the time of presentation: defined as the proportion of women with breast cancer diagnosed at early stage (stage 0, I, II) Time of outcome assessment: 3 years to 20 years Method of measurement: CBE · health workers

The intervention may leads to higher breast cancer stage at the time of presentation: defined as the… (low certainty).

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
RR 1.44 [1.01, 2.06]
3 studies · 593 participants
Low

Intervention not reported

Breast cancer stage at the time of presentation: defined as the proportion of women with breast cancer diagnosed at late stage (stage III, IV) Time of outcome assessment: 3 years to 20 years Method of measurement: CBE · health workers

The intervention may leads to lower breast cancer stage at the time of presentation: defined as the… (low certainty).

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
RR 0.58 [0.36, 0.94]
3 studies · 593 participants
Low

Intervention not reported

Accuracy of health worker‐performed CBE Time of outcome assessment: 2 years to 20 years Method of measurement: Sensitivity, specificity and positive predictive value · health workers

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
Very low

Intervention not reported

CBE coverage Time of outcome assessment: 20 years Method of measurement: active surveillance · health workers

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Moderate

Intervention not reported

Completion of · health workers

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Moderate

Intervention not reported

Breast cancer mortality: defined as deaths among women who received a diagnosis of breast cancer Time of outcome assessment: 3 years to 20 years Method of measurement: death registration offices, hospital records, and house visits · health workers

It is very uncertain whether the intervention changes breast cancer mortality: defined as deaths among women who received… (very low certainty).

1 finding from 1 review

Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income… 2023 · Cochrane Headline outcomes only
RR 0.88 [0.24, 3.26]
2 studies · 355 participants
Very low

Pharmacologic intervention vs placebo

Harmful alcohol use · alcohol use disorder

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Pharmacologic intervention vs another pharmacologic intervention

Different comparators · alcohol use disorder

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
1 participants
GRADE not reported

Brief intervention vs brief advice, information, or assessment only

Harmful alcohol use · people with hazardous or harmful alcohol consumption

2 findings from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
17 studies · 3913 participants
Very low
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1349 participants
Very low

Brief intervention vs brief advice, information, or assessment only

Retention [ · people with hazardous or harmful alcohol consumption

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 5380 participants
Very low

Other psychosocial intervention vs usual care, brief intervention, or wait list

Harmful alcohol use · people with hazardous or harmful alcohol consumption

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 2106 participants
Very low

Other psychosocial intervention vs usual care, brief intervention, or wait list

Retention [ · people with hazardous or harmful alcohol consumption

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1664 participants
Very low

Pharmacologic intervention vs placebo

Retention [ · alcohol use disorder

Pharmacologic intervention showed no clear difference in retention compared with placebo (low certainty).

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
RR 1.13 [0.89, 1.44]
3 studies · 247 participants
Low

Any Psychosocial intervention plus pharm vs psychosocial interventions

Harmful alcohol use · alcohol use disorder

2 findings from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 475 participants
Low
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
RR 0.62 [0.16, 2.47]
1 study · 102 participants
Very low

Any Psychosocial intervention plus pharm vs psychosocial interventions

Retention [ · alcohol use disorder

Pharmacologic intervention along with psychosocial intervention showed no clear difference in retention compared with psychosocial intervention alone (moderate certainty).

1 finding from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
RR 1.15 [0.95, 1.4]
3 studies · 363 participants
Moderate

Pharmacologic intervention vs another pharmacologic intervention

Harmful alcohol use ‐ not measured · alcohol use disorder

The review found no eligible studies for this question.

2 findings from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pharmacologic intervention vs another pharmacologic intervention

Retention [ · alcohol use disorder

Pharmacologic intervention showed no clear difference in retention compared with another pharmacologic intervention (low certainty).

2 findings from 1 review

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
RR 0.95 [0.76, 1.19]
2 studies · 190 participants
Low
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
RR 1.02 [0.96, 1.08]
2 studies · 200 participants
Low